AngioDynamics (ANGO) News Today $10.33 -0.26 (-2.46%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$10.33 0.00 (0.00%) As of 02/21/2025 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period White Pine Capital LLC Has $587,000 Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)White Pine Capital LLC raised its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 189.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,033 shares of the medical instruments supplier's stock aFebruary 15, 2025 | marketbeat.comSystematic Financial Management LP's Strategic Acquisition in AngioDynamics IncFebruary 13, 2025 | gurufocus.comShort Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Grows By 78.6%AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the recipient of a significant increase in short interest in January. As of January 31st, there was short interest totalling 1,470,000 shares, an increase of 78.6% from the January 15th total of 822,900 shares. Based on an average daily trading volume, of 677,900 shares, the short-interest ratio is currently 2.2 days.February 13, 2025 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Stock Passes Above 200-Day Moving Average - Should You Sell?AngioDynamics (NASDAQ:ANGO) Shares Pass Above 200 Day Moving Average - Here's What HappenedFebruary 11, 2025 | marketbeat.comAngioDynamics (ANGO) Down 14.2% Since Last Earnings Report: Can It Rebound?February 8, 2025 | msn.comAngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Down 11.8% in JanuaryAngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) saw a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 882,000 shares, a decrease of 11.8% from the December 31st total of 1,000,000 shares. Based on an average trading volume of 625,200 shares, the days-to-cover ratio is presently 1.4 days.January 31, 2025 | marketbeat.comAngioDynamics initiates Auryon Atherectomy System combination studyJanuary 30, 2025 | markets.businessinsider.comAngioDynamics (NASDAQ:ANGO) Hits New 12-Month High - Here's WhyAngioDynamics (NASDAQ:ANGO) Sets New 52-Week High - Should You Buy?January 30, 2025 | marketbeat.comAngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb IschemiaJanuary 30, 2025 | businesswire.comWith 74% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big gunsJanuary 25, 2025 | finance.yahoo.comAssenagon Asset Management S.A. Reduces Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Assenagon Asset Management S.A. reduced its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 35.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 272,307 shares of the medical instJanuary 23, 2025 | marketbeat.comInsider Selling: AngioDynamics, Inc. (NASDAQ:ANGO) SVP Sells 4,060 Shares of StockJanuary 18, 2025 | insidertrades.comAngioDynamics, Inc. (NASDAQ:ANGO) Stock Position Raised by JPMorgan Chase & Co.JPMorgan Chase & Co. boosted its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 28.7% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 553,161 shares of the medical instruments supplier's stock afterJanuary 18, 2025 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) SVP Warren Nighan, Jr. Sells 4,060 SharesAngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) SVP Warren Nighan, Jr. sold 4,060 shares of AngioDynamics stock in a transaction dated Thursday, January 16th. The shares were sold at an average price of $12.31, for a total value of $49,978.60. Following the transaction, the senior vice president now owns 41,817 shares of the company's stock, valued at $514,767.27. The trade was a 8.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.January 17, 2025 | marketbeat.comShort Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 11.8%AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the recipient of a large drop in short interest in December. As of December 31st, there was short interest totalling 882,000 shares, a drop of 11.8% from the December 15th total of 1,000,000 shares. Based on an average daily trading volume, of 625,200 shares, the days-to-cover ratio is presently 1.4 days.January 17, 2025 | marketbeat.comBarclays PLC Boosts Position in AngioDynamics, Inc. (NASDAQ:ANGO)Barclays PLC grew its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 81.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 83,582 shares of the medical instruments supplier's stock after acquiring an additJanuary 17, 2025 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Shares Up 6.2% - Time to Buy?AngioDynamics (NASDAQ:ANGO) Trading 6.2% Higher - What's Next?January 16, 2025 | marketbeat.comAngioDynamics Highlights Strategic Growth at Healthcare ConferenceJanuary 16, 2025 | tipranks.comAngioDynamics: Improving Financial Performance And Good Clinical Data Reinvigorate The SharesJanuary 16, 2025 | seekingalpha.comAngioDynamics Publishes APEX-AV Trial Results In JSCAIJanuary 14, 2025 | markets.businessinsider.comAngioDynamics (NASDAQ:ANGO) Shares Gap Down - Time to Sell?AngioDynamics (NASDAQ:ANGO) Shares Gap Down - Time to Sell?January 13, 2025 | marketbeat.comAngioDynamics announces publication of APEX-AV trial results in JSCAIJanuary 13, 2025 | markets.businessinsider.comAngioDynamics price target raised to $15 from $14 at H.C. WainwrightJanuary 10, 2025 | markets.businessinsider.comHC Wainwright Raises AngioDynamics (NASDAQ:ANGO) Price Target to $15.00HC Wainwright upped their target price on shares of AngioDynamics from $14.00 to $15.00 and gave the stock a "buy" rating in a report on Friday.January 10, 2025 | marketbeat.comAngioDynamics price target raised to $15 from $12 at CanaccordJanuary 10, 2025 | markets.businessinsider.comAngioDynamics, Inc. (NASDAQ:ANGO) Q2 2025 Earnings Call TranscriptJanuary 9, 2025 | msn.comAngioDynamics Inc (ANGO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...January 9, 2025 | gurufocus.comQ2 2025 AngioDynamics Inc Earnings Call TranscriptJanuary 9, 2025 | gurufocus.comAngioDynamics, Inc. Reports Growth in Med Tech SegmentJanuary 8, 2025 | tipranks.comAngioDynamics 2Q Loss Narrows, Revises FY25 OutlookJanuary 8, 2025 | marketwatch.comAngioDynamics Reports Fiscal Year 2025 Second Quarter Financial ResultsJanuary 8, 2025 | finanznachrichten.deAngioDynamics Inc. Q2 Loss Decreases, Beats EstimatesJanuary 8, 2025 | markets.businessinsider.comAngioDynamics Reports Growth and Advances NanoKnife SystemJanuary 8, 2025 | markets.businessinsider.comAngioDynamics hopes NanoKnife will become go-to prostate cancer treatmentJanuary 8, 2025 | msn.comAngioDynamics, Inc. (ANGO) Q2 2025 Earnings Call TranscriptJanuary 8, 2025 | seekingalpha.comAngioDynamics: A Surgical Approach To Market GrowthJanuary 8, 2025 | seekingalpha.comAngioDynamics (NASDAQ:ANGO) Reaches New 12-Month High After Better-Than-Expected EarningsAngioDynamics (NASDAQ:ANGO) Sets New 52-Week High Following Better-Than-Expected EarningsJanuary 8, 2025 | marketbeat.comAngioDynamics Hosts Virtual NanoKnife Investor EventJanuary 8, 2025 | tipranks.comAngioDynamics (NASDAQ:ANGO) Releases FY25 Earnings GuidanceAngioDynamics (NASDAQ:ANGO) updated its FY25 earnings guidance. The company provided EPS guidance of ($0.38)-($0.34) for the period, compared to the consensus estimate of ($0.40). The company also issued revenue guidance of $282-288 millionillion, compared to the consensus estimate of $283.86 millionillion.January 8, 2025 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Announces Quarterly Earnings ResultsAngioDynamics (NASDAQ:ANGO - Get Free Report) released its quarterly earnings data on Wednesday. The medical instruments supplier reported ($0.04) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.07. AngioDynamics had a negative net margin of 83.95% and a negative return on equity of 5.86%.January 8, 2025 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Releases FY 2025 Earnings GuidanceAngioDynamics (NASDAQ:ANGO) updated its FY 2025 earnings guidance. The company provided EPS guidance of -0.380--0.340 for the period, compared to the consensus estimate of -0.400. The company also issued revenue guidance of $282.0 millionillion-$288.0 millionillion, compared to the consensus estimate of $283.9 millionillion.January 8, 2025 | marketbeat.comAngioDynamics Non-GAAP EPS of -$0.04 beats by $0.07, revenue of $73.02M beats by $2.09MJanuary 8, 2025 | seekingalpha.comWhat To Expect From AngioDynamics Inc (ANGO) Q2 2025 EarningsJanuary 7, 2025 | gurufocus.comAngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ SystemJanuary 6, 2025 | finance.yahoo.comAngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife(TM) SystemJanuary 6, 2025 | stockhouse.comAngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnifeâ„¢ SystemJanuary 6, 2025 | businesswire.comAngioDynamics to Present at the J.P. Morgan Healthcare ConferenceJanuary 6, 2025 | businesswire.comAngioDynamics sells Warren County facilities, will remain at Queensbury plantDecember 29, 2024 | bizjournals.comShort Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Declines By 12.3%AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the recipient of a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 1,000,000 shares, a drop of 12.3% from the November 30th total of 1,140,000 shares. Based on an average daily trading volume, of 582,000 shares, the short-interest ratio is currently 1.7 days.December 29, 2024 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Shares Cross Above 200-Day Moving Average - Here's What HappenedAngioDynamics (NASDAQ:ANGO) Share Price Crosses Above 200-Day Moving Average - Here's What HappenedDecember 28, 2024 | marketbeat.com Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address ANGO Media Mentions By Week ANGO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANGO News Sentiment▼0.770.60▲Average Medical News Sentiment ANGO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANGO Articles This Week▼13▲ANGO Articles Average Week Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alphatec News Today Orthofix Medical News Today Surmodics News Today Accuray News Today Rockwell Medical News Today ReShape Lifesciences News Today Abbott Laboratories News Today Intuitive Surgical News Today Boston Scientific News Today Stryker News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANGO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANGO Stock Alerts